Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone

NCT00181558 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Adenocarcinoma of the Prostate

Interventions

DRUG: Atrasentan
DRUG: Zoledronic Acid (Zometa)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]